Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.Malcolm A. Smith, Richard S. Ungerleider, Bruce M. Camitta et al.|Journal of Clinical Oncology|1996Cited by 914
Structure-Based Design of Novel Dihydroalkoxybenzyloxopyrimidine Derivatives as Potent Nonnucleoside Inhibitors of the Human Immunodeficiency Virus Reverse TranscriptaseE. Sudbeck, Fatih M. Uckun|Antimicrobial Agents and Chemotherapy|1998Cited by 47